Attila Fejer will take over as general manager of US pharmaceutical company Eli Lilly’s Romanian subsidiary starting July 1.

He will replace Camilla Shen, who has been regional director for South-Eastern Europe and general manager for Romania since February last year.

Fejer previously worked as divisional director for the company’s biomedical products and oncological sections.

One of the priorities on his future agenda is establishing again a predictable business environment on the local pharma market, reports local Dailybusiness.ro. He also plans to expand the company’s portfolio in Romania targeting the auto-immune disease, diabetes, cancer, central nervous system and osteoporosis therapeutic areas.

editor@romania-insider.com